CCM chief defends demerger exercise


KUALA LUMPUR: Chemical Company of Malaysia Bhd’s (CCM) head honcho has defended the company’s demerger exercise as one that will not result in any losses to shareholders.

Speaking to reporters at a briefing here yesterday, CCM group managing director Leonard Ariff Abdul Shatar acknowledged that it would take time for the market to digest the recently announced corporate exercise to de-gear and demerge from its profit-making pharmaceutical unit CCM Duopharma Biotech Bhd.

Get 30% off with our ads free Premium Plan!

Monthly Plan

RM13.90/month
RM9.73 only

Billed as RM9.73 for the 1st month then RM13.90 thereafters.

Annual Plan

RM12.33/month
RM8.63/month

Billed as RM103.60 for the 1st year then RM148 thereafters.

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Business , CCM , CCM Duopharma , demerger , stock , shares ,

   

Next In Business News

Riding on S’pore’s market recovery
CIMB Bank, PayNet launch first payment infrastructure
Nissan, Honda mull merger to rival Toyota
Matrix redefining property landscape
Cargo volume growth likely to sustain in 2025
Rule of 78 removal might prompt banks to raise rates
Lower domestic PPI likely to keep inflation down
Bright outlook for renewable energy sector
SD Guthrie, EcoWorld, NS Corp ink deal
MRCB withdraws from high-speed rail consortium

Others Also Read